Akumin (Akumin) Cash And Cash Equivalents : $31.6 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Akumin Cash And Cash Equivalents?

Akumin's quarterly cash and cash equivalents declined from Mar. 2023 ($45.40 Mil) to Jun. 2023 ($37.97 Mil) but then stayed the same from Jun. 2023 ($37.97 Mil) to Sep. 2023 ($31.64 Mil).

Akumin's annual cash and cash equivalents increased from Dec. 2020 ($44.40 Mil) to Dec. 2021 ($48.42 Mil) and increased from Dec. 2021 ($48.42 Mil) to Dec. 2022 ($59.42 Mil).

Akumin Cash And Cash Equivalents Historical Data

The historical data trend for Akumin's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Cash And Cash Equivalents Chart

Akumin Annual Data

Trend

Sep15

Sep16

Sep17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

19.33

23.39

44.40

48.42

59.42

Akumin Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash And Cash Equivalents	Get a 7-Day Free Trial															59.36	59.42	45.40	37.97	31.64

Akumin Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Akumin (OTCPK:AKUMQ) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Akumin Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Akumin's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Akumin (Akumin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

AKU:Canada

Address

8300 West Sunrise Boulevard, Plantation, FL, USA, 33322

Website

https://www.akumin.com

Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.

Executives

Ronald J. Bienias	officer: Chief Restructuring Officer	C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp	10 percent owner, other: See Remarks	55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar	officer: See remarks	C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer	officer: See Remarks	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp	10 percent owner	3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey	10 percent owner	3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner	10 percent owner	3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis	officer: Chief Information Officer	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang	director	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron	officer: See Remarks	8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322